228 related articles for article (PubMed ID: 8871672)
1. The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity.
Keech CL; Gordon TP; McCluskey J
J Immunol; 1996 Oct; 157(8):3694-9. PubMed ID: 8871672
[TBL] [Abstract][Full Text] [Related]
2. Spreading of the immune response from 52 kDaRo and 60 kDaRo to calreticulin in experimental autoimmunity.
Kinoshita G; Keech CL; Sontheimer RD; Purcell A; McCluskey J; Gordon TP
Lupus; 1998; 7(1):7-11. PubMed ID: 9493142
[TBL] [Abstract][Full Text] [Related]
3. Restricted specificity of intermolecular spreading to endogenous La (SS-B) and 60 kDa Ro (SS-A) in experimental autoimmunity.
Gordon TP; Kinoshita G; Cavill D; Keech C; Farris A; Kaufman K; McCluskey J; Purcell A
Scand J Immunol; 2002 Aug; 56(2):168-73. PubMed ID: 12121436
[TBL] [Abstract][Full Text] [Related]
4. Molecular chaperones are targets of autoimmunity in Ro(SS-A) immune mice.
Kinoshita G; Purcell AW; Keech CL; Farris AD; McCluskey J; Gordon TP
Clin Exp Immunol; 1999 Feb; 115(2):268-74. PubMed ID: 9933452
[TBL] [Abstract][Full Text] [Related]
5. The 52-kd protein as a target of intermolecular spreading of the immune response to components of the SS-A/Ro-SS-B/La complex.
Tseng CE; Chan EK; Miranda E; Gross M; Di Donato F; Buyon JP
Arthritis Rheum; 1997 May; 40(5):936-44. PubMed ID: 9153557
[TBL] [Abstract][Full Text] [Related]
6. Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies.
Deshmukh US; Lewis JE; Gaskin F; Kannapell CC; Waters ST; Lou YH; Tung KS; Fu SM
J Exp Med; 1999 Feb; 189(3):531-40. PubMed ID: 9927515
[TBL] [Abstract][Full Text] [Related]
7. Ro60 peptides induce antibodies to similar epitopes shared among lupus-related autoantigens.
Deshmukh US; Lewis JE; Gaskin F; Dhakephalkar PK; Kannapell CC; Waters ST; Fu SM
J Immunol; 2000 Jun; 164(12):6655-61. PubMed ID: 10843726
[TBL] [Abstract][Full Text] [Related]
8. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A).
Topfer F; Gordon T; McCluskey J
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):875-9. PubMed ID: 7846070
[TBL] [Abstract][Full Text] [Related]
9. Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
Zampeli E; Mavrommati M; Moutsopoulos HM; Skopouli FN
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):134-141. PubMed ID: 32083547
[TBL] [Abstract][Full Text] [Related]
10. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
Peene I; Meheus L; De Keyser S; Humbel R; Veys EM; De Keyser F
Ann Rheum Dis; 2002 Oct; 61(10):929-33. PubMed ID: 12228166
[TBL] [Abstract][Full Text] [Related]
11. Latest update on the Ro/SS-A autoantibody system.
Schulte-Pelkum J; Fritzler M; Mahler M
Autoimmun Rev; 2009 Jun; 8(7):632-7. PubMed ID: 19393201
[TBL] [Abstract][Full Text] [Related]
12. Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-protein interactions.
Slobbe RL; Pluk W; van Venrooij WJ; Pruijn GJ
J Mol Biol; 1992 Sep; 227(2):361-6. PubMed ID: 1383550
[TBL] [Abstract][Full Text] [Related]
13. Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein.
Bozic B; Pruijn GJ; Rozman B; van Venrooij WJ
Clin Exp Immunol; 1993 Nov; 94(2):227-35. PubMed ID: 7693382
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the molecular composition of Ro ribonucleoprotein complexes. Identification of novel Y RNA-binding proteins.
Fabini G; Rutjes SA; Zimmermann C; Pruijn GJ; Steiner G
Eur J Biochem; 2000 May; 267(9):2778-89. PubMed ID: 10785401
[TBL] [Abstract][Full Text] [Related]
15. Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain.
Menor Almagro R; Jurado Roger A; Rodríguez Gutiérrez FJ; Solís Díaz R; Cardiel MH; Salaberri Maestrojuan JJ
Reumatol Clin; 2016; 12(5):256-62. PubMed ID: 26725021
[TBL] [Abstract][Full Text] [Related]
16. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
Gkoutzourelas A; Liaskos C; Mytilinaiou MG; Simopoulou T; Katsiari C; Tsirogianni A; Daoussis D; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Front Immunol; 2018; 9():2835. PubMed ID: 30581434
[TBL] [Abstract][Full Text] [Related]
17. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.
Kurien BT; Dsouza A; Igoe A; Lee YJ; Maier-Moore JS; Gordon T; Jackson M; Scofield RH
Clin Exp Immunol; 2013 Jul; 173(1):67-75. PubMed ID: 23607771
[TBL] [Abstract][Full Text] [Related]
18. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome.
Ricchiuti V; Isenberg D; Muller S
J Autoimmun; 1994 Oct; 7(5):611-21. PubMed ID: 7530962
[TBL] [Abstract][Full Text] [Related]
19. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins.
Scofield RH; Farris AD; Horsfall AC; Harley JB
Arthritis Rheum; 1999 Feb; 42(2):199-209. PubMed ID: 10025913
[TBL] [Abstract][Full Text] [Related]
20. IgV peptide mapping of native Ro60 autoantibody proteomes in primary Sjögren's syndrome reveals molecular markers of Ro/La diversification.
Wang JJ; Al Kindi MA; Colella AD; Dykes L; Jackson MW; Chataway TK; Reed JH; Gordon TP
Clin Immunol; 2016 Dec; 173():57-63. PubMed ID: 27609500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
